7 European Projects Found
Searched on 125080 European Projects
FINISHED
Cell and gene therapy based strategies to correct the bleeding phenotype in Hemophilia A (CGT hemophilia A)
Start date: May 1, 2011, End date: Apr 30, 2017,
Currently, haemophilia A cannot be cured. To prevent major bleeding episodes in haemophilia, human Factor VIII (FVIII) protein must be frequently administered as prophylaxis or on demand. This treatment is complicated by its high cost and development of antibodies that neutralize FVIII activity in 20 to 30% of the patients. Therefore, permanent solutions in the form of cell and gene therapy are ve ...
Read Project
1
Partner Participant
FINISHED
The MEtabolic Road to DIAstolic Heart Failure (MEDIA)
Start date: Jan 1, 2011, End date: Jun 30, 2016,
More than 50% of heart failure (HF) patients present without a major deficit of left ventricular (LV) systolic function and are presumed to suffer from diastolic HF (DHF) because diastolic LV distensibility is usually impaired in these patients. The vast majority (~80%) of DHF patients is exposed to metabolic risk factors. The MEDIA consortium therefore investigates:1) how metabolic derangements c ...
Read Project
23
Partners Participants
FINISHED
Addictions and Lifestyles In Contemporary Europe – Reframing Addictions Project (ALICE RAP)
Start date: Apr 1, 2011, End date: Mar 31, 2016,
ALICE RAP is a Europe wide project of 43 partner research institutions involving 107 researchers from 25 European countries providing 1000 months of a plurality of scientific endeavour to analyse the place and challenges of addictions and lifestyles to the cohesion, organization and functioning of contemporary European society. Through integrated multidisciplinary research, a wide range of factors ...
Read Project
46
Partners Participants
FINISHED
Transglutaminase in disease: a novel therapeutic target? (TRANSPATH)
Start date: Nov 1, 2011, End date: Oct 31, 2015,
"TRANSPATH is a multisectorial Network designed to facilitate the exchange of knowledge and technology between 7 leading European research teams and 3 SME partners and 2 associate SME Partners involved in basic and applied research into transglutaminase (TG) related human diseases. Its ambitions are to accelerate the development of new strategies for the treatment and diagnosis of human diseases ...
Read Project
12
Partners Participants
FINISHED
HCV Progress in Therapy with Novel Sialomimetic-chimeric inhibitors (HCV NEW INHIBITORS)
Start date: Oct 1, 2013, End date: Sep 30, 2015,
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV), which affects liver and is mainly transmitted by blood-to-blood contact. Infection is often asymptomatic, but when chronicized it causes liver inflammation (chronic hepatitis). This condition can progress to fibrosis, cirrhosis and cancer. Socio-economical quality of life is seriously affected by several aspects including ...
Read Project
8
Partners Participants
FINISHED
Disaster Training Curriculum (DITAC)
Start date: Jan 1, 2012, End date: Dec 31, 2014,
The EU aims to consolidate and enhance its disaster response capacity by creating a European Emergency Response Center. This institution should be complimented by a standardised European training curriculum for professional crisis response.A European multi-disciplinary team of experts is collaborating to develop a standardised curriculum for international crises management hereby referred to as DI ...
Read Project
13
Partners Participants
FINISHED
Point-Of-Care MONitoring and DIagnostics for Autoimmune Diseases (POCEMON)
Start date: Jan 1, 2008, End date: Aug 31, 2011,
The POCEMON project aims to the hardware and software development of a multi-purpose autoimmune diseases diagnostic platform by combining Lab-on-Chip (LOC) technologies, genomic microarrays of HLA (human leukocyte antigens) typing, microelectronics, mobile devices, intelligent algorithms and wireless communications. The multi-purpose platform will be provided as a portable integrated platform with ...
Read Project
